{"id":"W4213040106","doi":"10.1200/jco.2022.40.6_suppl.493","title":"Atezolizumab (atezo) with or without Bacille Calmette-Guérin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Cohort; Bladder cancer; Atezolizumab; Urology; Cystectomy; Internal medicine; Carcinoma in situ; Cancer; Oncology; Surgery; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009850205,0.0004756348,0.001067206,0.0001909885,0.0001574412,0.0006334399,0.000399184,0.0006606263,0.00155225],"category_scores_gemma":[0.0007416278,0.0002846957,0.001133557,0.0002954299,0.0003878714,0.0004695052,0.0002385458,0.001437905,0.000319064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004112064,"about_ca_system_score_gemma":0.0006218745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005584722,"about_ca_topic_score_gemma":0.002006109,"domain_scores_codex":[0.9997837,0.0001126997,0.00001774666,0.00003265469,0.00001798487,0.00003520106],"domain_scores_gemma":[0.9995757,0.0000952847,0.0001366693,0.00003052513,0.00002571854,0.0001360827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7431565,0.02776884,0.02896654,0.00171152,0.002742268,0.0001862645,0.0002373245,0.00181192,0.04270148,0.0001435836,0.002716008,0.1478578],"study_design_scores_gemma":[0.3820877,0.5443441,0.06239577,0.0001155439,0.001949137,0.0004492668,0.0001079552,0.00126837,0.003342294,0.0001459798,0.003766725,0.00002716766],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945397,0.003548735,0.00018041,0.0002222634,0.00006066577,0.0003733318,0.0004644039,0.00002608575,0.0005844252],"genre_scores_gemma":[0.9951579,0.002204842,0.0003882476,0.0003983494,0.00009070031,0.000304839,0.0008412835,0.000008961409,0.0006047642],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00155225,"threshold_uncertainty_score":0.005209386,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07484964919512821,"score_gpt":0.4236228981067292,"score_spread":0.348773248911601,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}